Invasive fungal infection in patients receiving chemotherapy for hematological malignancy: a multicenter, prospective, observational study in China

@article{Sun2014InvasiveFI,
  title={Invasive fungal infection in patients receiving chemotherapy for hematological malignancy: a multicenter, prospective, observational study in China},
  author={Yuqian Sun and He Huang and Jing Chen and Jianyong Li and Jun Ma and Juan Li and Yingmin Liang and Jianmin Wang and Yan Li and Kang Kang Yu and Jianda Hu and Jie Jin and Chun Chi Wang and Depei Wu and Yang Xiao and Xiao-Jun Huang},
  journal={Tumor Biology},
  year={2014},
  volume={36},
  pages={757-767}
}
This stud y examined the epidemiology, risk factors, management, and outcome of invasive fungal infection (IFI) in patients receiving chemotherapy for hematological malignancy in China. IFI risk factors were analyzed using univariate analysis and multivariate logistic regression. In total, 4,192 patients receiving 4,889 chemotherapy courses were enrolled [mean age 40.7 years, 58.4 % male, 16.9 % children (<18 years)]. The most common hematological diseases were acute myeloid leukemia (AML, 28.5… CONTINUE READING
BETA

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-10 OF 13 CITATIONS

Invasive Fungal Infections in Patients with Chronic Lymphoproliferative Disorders in the Era of Target Drugs

  • Mediterranean journal of hematology and infectious diseases
  • 2018
VIEW 9 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Primary fungal prophylaxis in acute leukemia patients with different risk factors: retrospective analysis from the CAESAR study

  • International journal of hematology
  • 2017
VIEW 5 EXCERPTS
CITES BACKGROUND & METHODS
HIGHLY INFLUENCED

Evaluation of the implementation rate of primary antifungal prophylaxis and the prognosis of invasive fungal disease in acute leukemia patients in China.

  • Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
  • 2017
VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 35 REFERENCES

Posaconazole vs. fluconazole as invasive fungal infection prophylaxis in China: a multicenter, randomized, open-label study.

  • International journal of clinical pharmacology and therapeutics
  • 2013
VIEW 15 EXCERPTS
HIGHLY INFLUENTIAL